Contact bioaccess®
Get a custom proposalThe World's First FIH-Only CRO for Startups
bioaccess® — The World's First CRO Purpose-Built for First-in-Human Clinical Trials
Healthcare startups developing breakthrough MedTech devices, Biopharma therapeutics, and Radiopharma treatments face a critical bottleneck: generating the clinical data investors and acquirers demand — before the money runs out. Traditional CROs are built for big pharma running Phase III mega-trials. They move slowly, charge premium rates, and treat early-stage startups as an afterthought.
bioaccess® was founded in 2010 to solve this exact problem. We are the world's first and only contract research organization built from day one exclusively around first-in-human clinical trials for healthcare startups.
Who We Serve: Seed-stage to growth-stage startups across MedTech, Biopharma, and Radiopharma — companies that need human proof-of-concept data to unlock their next milestone.
What Makes Us Different: Through our proprietary Innovation Runway — the world's first clinical development pathway built exclusively for FIH trials — we deliver ethics approval in 4–8 weeks, compress timelines by 40%, and reduce costs by 30% compared to US/EU-only approaches. Every study is 100% ICH-GCP aligned, producing FDA/EMA-ready data with no rework required. We operate across 10 countries in Latin America.
Since 2010, bioaccess® has accelerated 58+ companies from seed-stage startups to Fortune 500 MedTech.
Headquartered in Miami, FL. Learn more at bioaccessla.com.
-
Min project size
$50,000+
-
Hourly rate
Undisclosed
-
Employees
10 - 49
-
Year founded
Founded 2010
No have been added yet...
Have you worked with bioaccess®?
Share your experience working with bioaccess® on a past project by leaving a review for buyers around the world
Our Story
bioaccess® was born from a simple observation: healthcare startups need clinical data fast, but traditional CROs are built for big pharma timelines and budgets. Founded in 2010 in Miami, FL, we became the world's first CRO purpose-built for first-in-human (FIH) clinical trials for startups. Our team of 30+ professionals operates across 10 Latin American countries, delivering ICH-GCP compliant, FDA/EMA-ready data at 30-50% lower cost and 40% faster timelines than US/EU-only approaches.
Contact bioaccess®
If you’re not seeing exactly what you need here, send this company a custom message. You can talk about your project needs, price, and timeline to get started on your project.
Sign in to see which brands trust bioaccess®.
Get connected to see updates from bioaccess® like new case studies, latest reviews, their latest masterpieces in their portfolio, delivered straight to you.